Bangladesh, Sept. 3 -- At a time when Muhammad Yunus and his interim regime in Bangladesh face mounting uncertainty, pharma-giant Renata Limited – which emerged in 1993 after Bangladeshi owners acquired Pfizers local operations – has triggered a new wave of controversy that may seriously erode what remains of the administrations credibility. The companys failure to deliver on a crucial health supply contract has sparked suspicion of corporate sabotage, raising questions of whether Bangladesh is being pushed toward yet another foreign-engineered political upheaval. For many analysts, the unfolding crisis echoes the dramatic events of January 11, 2007, when the military intervened to impose a caretaker government amid political ...